There are 3 sub-families which is primarily based on the side chain:
Aliphatic and piperidine compounds:
Piperazine compounds:
The D2 receptors in the mesolimbic pathway.
Atypical drugs have a higher affinity for 5-HT2A receptor thus they block more serotonergic receptors than D2 receptors and it also blocks M1, H1 receptors, whereas typical drugs only block D2 receptors in the mesolimbic pathway.
Benzamides block both D2 and D3 receptors but the risk of EPS are reduced due to the localisation of D3 receptors in the limbic area.
Aliphatic compound also tends to have a lower potency thus have less EPS.
Extrapyramidal side effects are known to be caused by the blockade of D2 receptors in the nigrostriatal pathway, therefore drugs that block D2 receptors cause EPS.
Drugs known to cause EPS is the piperazine derivatives due to their high potency thus extensively blocking D2 receptors.
Autonomic side effects are caused by the blockage of alpha and cholinergic (muscarinic) receptors in the sympathetic and parasympathetic nervous systems